Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-07-31
2007-07-31
Rawlings, Stephen L. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388200, C435S332000
Reexamination Certificate
active
10727211
ABSTRACT:
The invention provides antibodies that specifically bind a membrane protease complex, the complex consisting of two homodimers of seprase and dipeptidyl peptidase IV (DPPIV), obtained from mammalian, preferably human cell membranes. The antibodies specifically bind the DPPIV protease of the seprase-DPPIV complex. This membrane protease complex resides on cell surface invadopodia at the leading edge of angiogenic endothelia, migratory fibroblasts, and invading cancer cells. The antibodies and immunoconjugates of the invention specifically bind the membrane protease complex at the cell surface invadopodia, yet fail to react with resting cells in adjacent human tissues and blood vessels. These antibodies and immunoconjugates block interaction of collagen matrix with the seprase-DPPIV complex in the invasive cells during angiogenesis and cancer spreading but not that with other endothelia or tumor cells. The invention further provides methods for identifying and of using DPPIV antagonists to inhibit capillary sprouting, angiogenesis and cancer invasion in tumor tissues and metastases. Also provided are therapeutic compositions comprising DPPIV antagonists.
REFERENCES:
patent: 5092885 (1992-03-01), Yamada et al.
patent: 5221622 (1993-06-01), Chen
patent: 5545405 (1996-08-01), Page
patent: 5753230 (1998-05-01), Brooks et al.
patent: 5942385 (1999-08-01), Hirth
patent: 5980896 (1999-11-01), Hellstrom et al.
patent: 6123941 (2000-09-01), Bissell et al.
patent: 6193968 (2001-02-01), Carron et al.
patent: 6258597 (2001-07-01), Bachovchin et al.
patent: 2003/0138432 (2003-07-01), Glazier
patent: WO96/38550 (1996-12-01), None
Abbott et al. (Eur. J. Biochem. 1999; 266: 798-810).
Greenspan et al. (Nature Biotechnology. 1999; 7: 936-937).
George et al. (Circulation. 1998; 97: 900-906).
Stancoviski et al. (Proceedings of the National Academy of Science USA. 1991; 88: 8691-8695).
Jiang et al. (J. Biol. Chem. Feb. 11, 2005; 280 (6): 4656-4662).
Dong, R.P., et al., “Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function”,Molecular Immunology1998, 35(1):13-21.
Ghersi, G., et al., “Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex”,Journal of Biological Chemistry2002, 277(32):29231-29241.
Loster, K., et al., “The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site”,Biochemical and Biophysical Research Communications1995, 217(1):341-348.
Zukowska-Grojec, Z., et al., “Neuropeptide Y.A novel angiogenic factor from the sympathetic nerves and endothelium”,Circulation Research1998, 83(2):187-195.
J. Heins, P. Welker, Chr. Schönlein, I. Born, B. Hartrodt, K. Neubert, D. Tsuru and A. Barth, “Mechanism of proline-specific proteinases: (I) substrate specificity of dipeptidyl peptidase IV from pig kidney and proline-specific endopeptidase fromFlavobacterium meningosepticum,” Biochimica et Biophysica Acta(1988) 954:161-169.
Wen-Tien Chen and Jaw-Yuan Wang, “Specialized Surface Protrusions of Invasive Cells, Invadopodia and Lamellipodia, Have Differential MT1-MMP, MMP-2, and TIMP-2 Localization,”Annals of the New York Acad. Of Sciences(1999) 878: 361-371.
Susette C. Mueller, Giulio Ghersi, Steven K. Akiyama, Qing-Xiang Amy Sang, Linda Howard, Mayra Pineiro-Sanchez, Hirokazu Nakahara, Yunyun Yeh, and Wen-Tien Chen, “A Novel Protease-docking Function of Integrin at Invadopodia”,The Journal of Biological Chemistry(1999) 274/35: 24947-24952.
Donald Ingber and Judah Folkman, “Inhibition of Angiogenesis Through Modulation of Collagen Metabolism,”Laboratory Investigation. (1988) 59/1:. 44-51.
Marsha A. Moses, Judith Sudhalter, Robert Langer, “Identification of an Inhibitor of Neovascularization from Cartilage,”Science1990, 248: 1408-1410.
Christine H. Blood and Bruce R. Zetter, “Tumor interactions with the vasculature: angiogenesis and tumor metastasis,”Biochimica et Biophysica Acta(1990) 1032: 89-118.
Leslie A. Goldstein and Wen-Tien Chen, “Identification of an Alternatively Spliced Seprase mRNA That Encodes a Novel Intracellular Isoform,”The Journal of Biological Chemistry(2000) 275/4: 2554-2559.
Wanda Auerbach and Robert Auerbach, “Angiogenesis Inhibition: A Review,”Pharmac. Ther. (1994) 63: 265-311.
Rakesh K. Jain, “Vascular and interstitial barriers to delivery of therapeutic agents in tumors,”Cancer and Metastasis Reviews(1990) 9: 253-266.
Sally S. Seaver, Ph.D., “Monoclonal Antibodies in Industry: More Difficult Than Originally Thought,”Genetic Engineering News(1994) 14/14: 10 and 21.
William J. Harris and Steven Emery, “Therpeutic antibodies—the coming of age,”Trends in Biotechnology(1993) 11: 42-44.
Trisha Gura “Systems for Identifying New Drugs Are Often Faulty,”Science(1997) 278: 1041-1042.
Eryl Liddell and Ian Weeks “Antibody Technology”Bios Scientific Publishers(1995) 23-44.
Sabine Hartel-Schenk, Nikolaus Loch, Martin Zimmermann and Werner Reutter, “Development of monoclonal antibodies against different protein and carbohydrate epitopes of dipeptidyl peptidase IV from rat liver plasma membranes,”Eur. J. Biochem(1991) 196: 349-355.
Dirk Reinhold, Ute Bank, Frank Bühling, Klaus Neubert, Taila Mattern, Artur Jochen Ulmer, Hans-Dieter Flad, and Siegfried Ansorge, “Dipeptidyl Peptidase IV (CD26) on Human Lymphocytes. Synthetic Inhibitors of and Antibodies against Dipeptidyl Peptidase IV Suppress the Proliferation of Pokeweed Mitogen-Stimulated Peripheral Blood Mononuclear Cells, and IL-2 and IL-6 Production,”Immunobiology(1993) 188: 403-414.
J.J. Van Den Oord, “Expression of CD26/dipeptidyl-peptidase IV in benign and malignant pigment-cell lesions of the skin,”British Journal of Dermatology(1998) 138: 615-621.
Hung-Chi Cheng, Mossaad Abdel-Ghany, Randolph C. Elble, and Bendicht U. Pauli, “Lung Endothelial Dipeptidyl Peptidase IV Promotes Adhesion and Metastasis of Rat Breast Cancer Cells via Tumor Cell Surface-associated Fibronectin,”The Journal of Biological Chemistry(1998) 273/37: 24207-24215.
T. Mattern, A. C. Feller, B. Kniep, H. -D. Flad, and A. J. Ulmer, “Comparative studies on three monoclonal antibodies (anti DPPIV, anti Ta1, IOT15) recognizing antigens clustered in Cdw26,”Immunobiology(1988) 178(1/2): 110, Abstract H.12.
Arao, Shuichi, et al., “β1 Integrins Play an Essential Role in Adhesion and Invasion of Pancreatic Carcinoma Cells”,Pancreas2000, 20(2):129-137.
Barbet, Jacques, et al., “Pretargeting with the Affinity Enhancement System for Radioimmunotherapy”,Cancer Biotherapy&Radiopharmaceuticals1999, 14(3):153-166.
Duke-Cohan, Jonathan, et al., “Targeting of an Activated T-Cell Subset Using a Bispecific Antibody-Toxin Conjugate Directed Against CD4 and CD26”,Blood1993, 82(7):2224-2234.
Elble, R.C., et al., “Lu-ECAM-1 and DPP IV in Lung Metastasis”,Curr. Top Microbiol Immunol1996, 213(1):107-122.
Fukushima, Yuji, et al., “Integrin α3β1-Mediated Interaction with Laminin-5 Stimulates Adhesion, Migration and Invasion of Malignant Glioma Cells”,Int. J. Cancer1998, 76:63-72.
Abdel-Ghany, Mossaad, et al., “Truncated Dipeptidyl Peptidase IV is a Potent Anti-Adhesion and Anti-Metastasis Peptide for Rat Breast Cancer Cells”,Invasion Metastatis1998, 18:35-43.
Ghersi, Guilio, et al., “Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding”,Peptides2001, 22:453-458.
Johnson, Robert C., et al., “Lung Endothelial Dipeptidyl IV is an Adhesion Molecule for Lung-metastatic Rat Breast and Prostate Carcinoma Cells”,The Journal of Cell Biology1993, 121(6):1423-1432.
Klominek, Julius, et al., “Differential Motile Response of Human Malignant Mesothelioma Cells to Fibronectin, Laminin and Collagen Type IV:
Hoffmann & Baron , LLP
Rawlings Stephen L.
The Research Foundation at State University of New York
LandOfFree
Compositions and methods for inhibition of cancer invasion... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for inhibition of cancer invasion..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inhibition of cancer invasion... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3783299